Efficacy and safety of Hou Gu Mi Xi in patients with spleen qi deficiency syndrome who underwent radical gastrectomy for gastric cancer: protocol for a multicenter, randomized, double-blind, placebo-controlled trial

Peer Review reports

Original Submission
27 Sep 2018	Submitted	Original manuscript
2 Mar 2019	Reviewed	Reviewer Report - Zhaoxiang Bian
28 Mar 2019	Reviewed	Reviewer Report - Allan Hackshaw
24 Apr 2019	Author responded	Author comments - Xu Zhou
Resubmission - Version 2
24 Apr 2019	Submitted	Manuscript version 2
30 Apr 2019	Author responded	Author comments - Xu Zhou
Resubmission - Version 3
30 Apr 2019	Submitted	Manuscript version 3
Publishing
13 May 2019	Editorially accepted
10 Jun 2019	Article published	10.1186/s13063-019-3429-x

Back to article page